Cargando…

Medicare part D prescribing for direct oral anticoagulants in the United States: Cost, use and the “rubber effect”

INTRODUCTION: Direct oral anticoagulants (DOAC) have gained an increased share over warfarin for prevention and treatment of thromboembolic disease. We studied DOAC adoption across providers and medical specialties. METHODS: Retrospective, cross-sectional analysis of Medicare Part D public use files...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ziakas, Panayiotis D., Kourbeti, Irene S., Poulou, Loukia S., Vlachogeorgos, Georgios S., Mylonakis, Eleftherios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5991647/ https://www.ncbi.nlm.nih.gov/pubmed/29879194 http://dx.doi.org/10.1371/journal.pone.0198674

Ejemplares similares

Comparative Analysis of Mortality From Coronavirus Disease 2019 Across the European Union Countries and the Effects of Vaccine Coverage
por: Ziakas, Panayiotis D, et al.
Publicado: (2022)

Web search popularity, publicity, and utilization of direct oral anticoagulants in the United States, 2008–2018: A STROBE-compliant study
por: Ziakas, Panayiotis D., et al.
Publicado: (2020)

Spatial association patterns between post-acute care services and acute care facilities in the United States
por: Ziakas, Panayiotis D., et al.
Publicado: (2020)

The Cost-effectiveness of Cefazolin Compared With Antistaphylococcal Penicillins for the Treatment of Methicillin-Sensitive Staphylococcus aureus Bacteremia
por: Pliakos, Elina Eleftheria, et al.
Publicado: (2021)

Public interest trends for Covid-19 and alignment with the disease trajectory: A time-series analysis of national-level data
por: Ziakas, Panayiotis D., et al.
Publicado: (2023)

Correlation of antimicrobial prescription rate and county income in medicare part D
por: Volpi, Connor, et al.
Publicado: (2019)

Clinician Trends in Prescribing Direct Oral Anticoagulants for US Medicare Beneficiaries
por: Wheelock, Kevin M., et al.
Publicado: (2021)

Economic Analysis of Infectious Disease Consultation for Staphylococcus aureus Bacteremia Among Hospitalized Patients
por: Pliakos, Elina Eleftheria, et al.
Publicado: (2022)

The cost-effectiveness of empirical antibiotic treatments for high-risk febrile neutropenic patients: A decision analytic model
por: Tori, Katerina, et al.
Publicado: (2020)

Adaptation of Cost Analysis Studies in Practice Guidelines
por: Zervou, Fainareti N., et al.
Publicado: (2015)

The role of county-level socioeconomic status on brand-name prescriptions in Medicare part D: A cross-sectional Study
por: Volpi, Connor, et al.
Publicado: (2020)

Trends and Significance of VRE Colonization in the ICU: A Meta-Analysis of Published Studies
por: Ziakas, Panayiotis D., et al.
Publicado: (2013)

Graft-Versus-Host Disease Prophylaxis after Transplantation: A Network Meta-Analysis
por: Ziakas, Panayiotis D., et al.
Publicado: (2014)

Physician Payments from Industry Are Associated with Greater Medicare Part D Prescribing Costs
por: Perlis, Roy H., et al.
Publicado: (2016)

Prevalence of Clostridium difficile Infection among Solid Organ Transplant Recipients: A Meta-Analysis of Published Studies
por: Paudel, Suresh, et al.
Publicado: (2015)

The Role of TLR4 896 A>G and 1196 C>T in Susceptibility to Infections: A Review and Meta-Analysis of Genetic Association Studies
por: Ziakas, Panayiotis D., et al.
Publicado: (2013)

Visualizing nationwide variation in medicare Part D prescribing patterns
por: Rosenberg, Alexander, et al.
Publicado: (2018)

The Impact of Antimicrobial Resistance and Aging in VAP Outcomes: Experience from a Large Tertiary Care Center
por: Arvanitis, Marios, et al.
Publicado: (2014)

Asymptomatic Carriers of Toxigenic C. difficile in Long-Term Care Facilities: A Meta-Analysis of Prevalence and Risk Factors
por: Ziakas, Panayiotis D., et al.
Publicado: (2015)

Regional variation in antibiotic prescribing among medicare part D enrollees, 2013
por: Arizpe, Andre, et al.
Publicado: (2016)

Utilization and prescribing patterns of direct oral anticoagulants
por: Whitworth, Maegan M, et al.
Publicado: (2017)

Prevalence and impact of Clostridium difficile infection in elderly residents of long-term care facilities, 2011: A nationwide study
por: Ziakas, Panayiotis D., et al.
Publicado: (2016)

Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data
por: Sharma, Manvi, et al.
Publicado: (2018)

Prescribing trends of proton pump inhibitors, antipsychotics and benzodiazepines of medicare part d providers
por: Toth, Jennifer M., et al.
Publicado: (2022)

Comparison of Generic Prescribing Patterns Among 340B-Eligible and Non-340B Prescribers in the Medicare Part D Program
por: Dickson, Sean, et al.
Publicado: (2023)

The opioid prescribing practices of surgeons: A comprehensive review of the 2015 claims to Medicare Part D
por: Khalid, Syed I., et al.
Publicado: (2019)

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population
por: Amin, Alpesh, et al.
Publicado: (2018)

A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population
por: Amin, Alpesh, et al.
Publicado: (2020)

658. Cost-effectiveness of Molecular Diagnostic Assays for the Therapy of Severe Sepsis and Septic Shock in the Emergency Department
por: Zacharioudakis, Ioannis, et al.
Publicado: (2019)

Combined rheolytic thrombectomy and stent placement in SVC and brachiocephalic vein thrombosis due to metastatic lymphadenopathy
por: Ptohis, Nikolaos, et al.
Publicado: (2015)

Medicare Part D and Cost-Sharing for Antiretroviral Therapy and Preexposure Prophylaxis
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Trends in Anticoagulation Prescription Spending Among Medicare Part D and Medicaid Beneficiaries Between 2014 and 2019
por: Duvalyan, Angela, et al.
Publicado: (2021)

1105. Statewide, Retrospective, Cohort Study of Medicare Part B Quinolone Prescribing for Cystitis in 2016–2017
por: Yu, Joyce, et al.
Publicado: (2019)

Promoting Interprofessional Collaboration: Pharmacy Students Teaching Current and Future Prescribers About Medicare Part D
por: Lai, Cindy J., et al.
Publicado: (2011)

Identifying Higher-Volume Antibiotic Outpatient Prescribers Using Publicly Available Medicare Part D Data — United States, 2019
por: Gouin, Katryna A., et al.
Publicado: (2022)

Direct Cost Analysis of Outpatient Arthroscopic Rotator Cuff Repair in Medicare and Non-Medicare Populations
por: Narvy, Steven J., et al.
Publicado: (2016)

Impact of Higher Insulin Prices on Out-of-Pocket Costs in Medicare Part D
por: Tseng, Chien-Wen, et al.
Publicado: (2020)

Availability of Cost-effectiveness Studies for Drugs With High Medicare Part D Expenditures
por: Tisdale, Rebecca L., et al.
Publicado: (2021)

Antibiotic Prescribing in New York State Medicare Part B Beneficiaries Diagnosed With Cystitis Between 2016 and 2017
por: Yu, Joyce Y, et al.
Publicado: (2020)

Characteristics of patients associated with any outpatient antibiotic prescribing among Medicare Part D enrollees, 2007–2018
por: Kim, Christine Y., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v8el1nseiu4vq8j5uka6bh3fsm